Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016

Abstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelli...

Full description

Bibliographic Details
Main Authors: Jonas Johansson, Bjørn Heine Strand, Bente Morseth, Laila Arnesdatter Hopstock, Sameline Grimsgaard
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Geriatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12877-020-01860-w
id doaj-3e2d31083d73424382947a4d9b8fc66c
record_format Article
spelling doaj-3e2d31083d73424382947a4d9b8fc66c2020-11-25T04:09:53ZengBMCBMC Geriatrics1471-23182020-11-0120111110.1186/s12877-020-01860-wDifferences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016Jonas Johansson0Bjørn Heine Strand1Bente Morseth2Laila Arnesdatter Hopstock3Sameline Grimsgaard4Department of Community Medicine, UiT The Arctic University of NorwayDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public HealthSchool of Sport Sciences, UiT The Arctic University of NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayAbstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. Results Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALMheight 2) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). Conclusions Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia.http://link.springer.com/article/10.1186/s12877-020-01860-wSarcopeniaPrevalenceEWGSOP2CohortThe Tromsø study
collection DOAJ
language English
format Article
sources DOAJ
author Jonas Johansson
Bjørn Heine Strand
Bente Morseth
Laila Arnesdatter Hopstock
Sameline Grimsgaard
spellingShingle Jonas Johansson
Bjørn Heine Strand
Bente Morseth
Laila Arnesdatter Hopstock
Sameline Grimsgaard
Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
BMC Geriatrics
Sarcopenia
Prevalence
EWGSOP2
Cohort
The Tromsø study
author_facet Jonas Johansson
Bjørn Heine Strand
Bente Morseth
Laila Arnesdatter Hopstock
Sameline Grimsgaard
author_sort Jonas Johansson
title Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_short Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_full Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_fullStr Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_full_unstemmed Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
title_sort differences in sarcopenia prevalence between upper-body and lower-body based ewgsop2 muscle strength criteria: the tromsø study 2015–2016
publisher BMC
series BMC Geriatrics
issn 1471-2318
publishDate 2020-11-01
description Abstract Background The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends grip strength and chair stand tests to be used as primary defining measures. It is unclear how either test affects prevalence estimates. Methods This cross-sectional study involved 3498 community-dwelling participants (40–84 years) from the 7th Tromsø Study survey (2015–2016). We used grip strength, five-repetition chair stands, four-meter Walk Speed Test, Timed-Up-and-Go (TUG) and Dual-Energy X-ray Absorptiometry measurements. Data were analyzed using multiple linear regression models and ROC-curves. Results Probable and confirmed sarcopenia prevalence was 1.3 and 4.4% based on grip strength and chair stands, respectively. There was very low agreement between grip strength and chair stand cut-offs (κ = 0.07), with only 4.3% of participants defined as having probable sarcopenia overlapping in the two criteria. Participants with grip strength-based sarcopenia had lower mean height, weight, waist circumference, and appendicular lean mass relative to body height (ALMheight 2) than non-sarcopenic participants (all p < 0.001), after adjusting for multiple covariates. Conversely, participants with chair stand-based sarcopenia had similar height, higher weight, waist circumference and body fat% compared to non-sarcopenic participants (all p < 0.05). Area-under-curves (AUCs) for TUG-time were significantly larger when using chair stand instead of grip strength cut-offs (0.86, 95% CI 0.84–0.89 vs. 0.75, 95% CI 0.69–0.83). Conclusions Using chair stands instead of grip strength more than doubled probable sarcopenia prevalence across all ages. The two measures defined individuals of contradictory anthropometrics, body composition, and dissimilar physical function to have probable sarcopenia. Researchers should further evaluate the consequences of using different strength measures in the EWGSOP2 definition to classify sarcopenia.
topic Sarcopenia
Prevalence
EWGSOP2
Cohort
The Tromsø study
url http://link.springer.com/article/10.1186/s12877-020-01860-w
work_keys_str_mv AT jonasjohansson differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016
AT bjørnheinestrand differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016
AT bentemorseth differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016
AT lailaarnesdatterhopstock differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016
AT samelinegrimsgaard differencesinsarcopeniaprevalencebetweenupperbodyandlowerbodybasedewgsop2musclestrengthcriteriathetromsøstudy20152016
_version_ 1724421446005948416